EDISON, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”) today announced the pricing of its offering of $225,000,000 aggregate principal amount of 6.75% convertible senior notes due 2030 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering ...

BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company" or “TRX”), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. (“Ucare”), the sole operator of China’s only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wh ...

Highlights: Immuron on track to exceed A$7 million in Sales this financial yearUniformed Services University anticipates topline results of Travelan® clinical study in October 2025Immuron anticipates IMM-529 (Clostridiodes difficile infection) IND submission to the FDA in August 2025Launch plans underway for ProIBS® in AustraliaImmuron anticipates IMM-986 (Vancomycin-resistant enterococci) pre-clinical research results in August 2025 MELBOURNE, Australia, May 30, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (AS ...

Core Insights - Zymeworks Inc. announced the conditional approval of zanidatamab by the National Medical Products Administration (NMPA) in China for treating previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC), marking it as the first dual HER2-targeted bispecific antibody approved for this indication in China [1][10] - The approval is a significant advancement for patients with HER2-positive BTC, a group with high unmet medical needs and poor prognoses, and reflects the clinical potential of zanidatamab [2][4] - Zymeworks has received $61 million in upfront and milestone payments from its collaboration partner BeOne Medicines, with an additional $20 million milestone payment linked to the NMPA approval and potential for up to $144 million in further milestones [2][6] Company Overview - Zymeworks is a clinical-stage biotechnology company focused on developing multifunctional biotherapeutics for difficult-to-treat diseases, including cancer, inflammation, and autoimmune diseases [1][6] - The company utilizes its proprietary Azymetric™ technology to engineer and develop zanidatamab, which targets HER2 and induces various mechanisms leading to tumor growth inhibition [5][7] - Zymeworks has strategic partnerships with BeOne Medicines and Jazz Pharmaceuticals, granting exclusive rights for the development and commercialization of zanidatamab in different territories [7] Industry Context - Biliary tract cancers account for approximately 3% of all digestive system tumors, with a rising incidence rate globally, particularly in Asia [4] - Approximately 11%-25.2% of patients with BTC are HER2-positive, making HER2 a validated target for antitumor therapy [4] - Zanidatamab has also received FDA approval in the U.S. and is under regulatory review in the EU, indicating its potential as a best-in-class treatment for HER2-expressing cancers [3][7]

OKOTOKS, Alberta, May 30, 2025 (GLOBE NEWSWIRE) -- (TSX: MTL) Mullen Group Ltd. ("Mullen Group", "We", "Our" and/or the "Corporation") is pleased to announce the closing of the acquisition of Cole Group Inc., Cole International Inc., Abco International Freight Inc. and all related entities (collectively the "Cole Group") effective June 1, 2025. Founded in the 1920s, the Cole Group is an industry leading full spectrum logistics services company specializing in customs brokerage, freight forwarding and trade ...

Core Insights - Aurora Mobile Limited has integrated the DeepSeek-R1-0528 AI model into its GPTBots.ai platform, enhancing its capabilities to compete with major players like OpenAI and Google [1][2][7] - The DeepSeek-R1-0528 model shows significant improvements in reasoning and coding performance, with AIME 2025 accuracy increasing from 70% to 87.5% and LiveCodeBench performance rising from 63.5% to 73.3% [2][3] - The model's open-source nature under the MIT License allows for commercial use and customization, aligning with the company's strategy to provide flexible AI solutions [5][6] Company Overview - Aurora Mobile, founded in 2011, is a leading provider of customer engagement and marketing technology services in China, focusing on stable messaging services and digital transformation solutions [11] - The company has developed various solutions, including Cloud Messaging and Cloud Marketing, to help enterprises achieve omnichannel customer reach [11] Product Features - The DeepSeek-R1-0528 model features a reduced hallucination rate and supports JSON output and function calling, facilitating seamless integration into business workflows [3][6] - A distilled version, DeepSeek-R1-0528-Qwen3-8B, is available for enterprises with limited compute resources, requiring only 16 GB of GPU memory while maintaining high performance [4] Market Implications - The integration of DeepSeek-R1-0528 enhances GPTBots.ai's ability to deliver advanced AI solutions across various industries, including finance, healthcare, education, and e-commerce [6][8] - The release highlights the growing potential of open-source AI models in enterprise applications, positioning GPTBots.ai to stay competitive in the evolving AI landscape [7]

Core Viewpoint - Trifork Group has initiated a share buyback program to repurchase shares, which is expected to enhance shareholder value and manage capital effectively [1][2]. Share Buyback Program - The share buyback program commenced on 4 March 2025 and will continue until 30 June 2025, with a total budget of DKK 14.92 million (approximately EUR 2 million) [1][2]. - As of the latest report, Trifork has repurchased a total of 99,074 shares for a total amount of DKK 8,646,363, with an average purchase price of DKK 87.27 [2]. Treasury Shares - Prior to the buyback, Trifork held 256,329 treasury shares, which accounted for 1.3% of the share capital. After the buyback, the total number of treasury shares increased to 331,090, representing 1.7% of the total registered shares [2][4]. - The total number of registered shares in Trifork is 19,744,899, leading to 19,413,809 outstanding shares after adjusting for treasury shares [4]. Utilization of Shares - Shares acquired through the buyback program have been utilized for executive management compensation, with 4,370 shares used for monthly salaries and 19,943 shares for the RSU plan [3].

Core Viewpoint - eQ Plc reported a significant transaction involving the disposal of shares by a closely associated person, indicating potential shifts in ownership dynamics within the company [1]. Group Information - eQ Group is a Finnish company specializing in asset management and corporate finance, managing approximately EUR 13.6 billion in assets [1]. - eQ Asset Management provides a variety of services, including private equity funds and real estate asset management for both institutions and individuals [1]. - Advium Corporate Finance, part of eQ Group, offers services related to mergers and acquisitions, real estate transactions, and equity capital markets [1]. Transaction Details - The transaction involved the disposal of 693,160 shares at a unit price of EUR 11.73, executed on May 28, 2025, on NASDAQ HELSINKI LTD [1]. - The aggregated volume of the transaction was 693,160 shares, with a volume-weighted average price of EUR 11.73 [1].

Group 1 - Oma Savings Bank Plc is a solvent and profitable Finnish bank with approximately 600 professionals providing services through 48 branch offices and digital channels to over 200,000 customers [2] - The bank focuses primarily on retail banking operations, offering a wide range of banking services, including credit, investment, and loan insurance products, as well as mortgage banking [2] - The core idea of OmaSp is to provide personal service and maintain a close relationship with customers through both digital and traditional channels, aiming for a premium customer experience [3] Group 2 - The personnel at OmaSp are committed to customer-oriented service development, and the bank supports their career growth through diverse tasks and continuous development [3] - A significant portion of the personnel also owns shares in OmaSp, indicating a vested interest in the bank's performance [3]

eQ Plc Stock Exchange Release30 May 2025, at 11.00 a.m. eQ Plc has on 29 May 2025, received a notification under Chapter 9, Section 5 of the Finnish Securities Market Act, according to which Rettig Oy Ab’s holding in eQ Plc’s shares and votes has fallen below 15.00 percent. The change in ownership is due to Rettig Oy Ab’s sale of shares on 28 May 2025 to eQ Plc’s CEO elect, Jouko Pölönen, as announced on 5 May 2025. On 28 May 2025, Rettig Oy Ab’s holding fell to 14.55 percent of eQ Plc’s shares and votes ...